US Patent 8410047 Counteracting drug-induced obesity using GLP-1 agonists
Patent 8410047 was granted and assigned to Novo Nordisk on April, 2013 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 31, 2005
Date of Patent
April 2, 2013
Patent Application Number
11629238
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8410047 Counteracting drug-induced obesity using GLP-1 agonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.